Brachial plexus neuropathy

Summary

Brachial plexus neuropathy (MONDO:0006683) is a disease (an umbrella term covering 7 Mondo subtypes) and 3 clinical trials. A subtype of nerve plexus disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Umbrella term: 7 Mondo subtypes
• Clinical trials: 3

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	brachial plexus neuropathy
Mondo ID	MONDO:0006683
EFO	EFO:1000844
MeSH	D020516
DOID	DOID:3690
NCIT	C27194
SNOMED CT	3548001
UMLS	C0700251
MedGen	148580
GARD	0024459
Anatomy (UBERON)	UBERON:0001814
Is cancer (heuristic)	no

Also known as: brachial nerve plexus peripheral neuropathy · brachial plexopathy · peripheral neuropathy of brachial nerve plexus

Disease family

This is a subtype of nerve plexus disorder. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › nervous system disorder › peripheral nervous system disorder › peripheral neuropathy › nerve plexus disorder › brachial plexus neuropathy

Related subtypes (3): lumbosacral plexus lesion, nerve plexus neoplasm, radiation-induced plexopathy

Subtypes (7): radial neuropathy, median nerve neuropathy, brachial plexus neoplasm, brachial plexus neuropathy from injury, brachial plexus neuritis, ulnar neuropathy, amyotrophic neuralgia

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

Drugs indicated or in trials for this disease

No drug has an approved disease-direct ChEMBL indication for this disease.

3 drugs in clinical trials for this disease (phase 2–3, investigational): efficacy not established — a trial record, not an indication.

Drug	Highest phase
Clodronic Acid	Phase 3
Pentoxifylline	Phase 3
Tocopherol Acetate	Phase 3

Clinical trials & evidence

Clinical trials

Clinical trials: 3.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	2
PHASE4	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT03780322	PHASE4	COMPLETED	Effectiveness of Armeo Spring Pediatric in Obstetric Brachial Plexus Injury
NCT04649749	Not specified	COMPLETED	Central Programming in Patients With a Bionic Hand After Traumatic Brachial Plexus Injury
NCT04654286	Not specified	UNKNOWN	Human Amniotic Membrane and Mesenchymal Stem Cells Composite